Spectrum Pharmaceuticals, Inc. Sales Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Maximizing the growth potential for our marketed drugs, Fusilev and Zevalin. The companys near-term outlook depends on sales and marketing successes associated with our two...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
NY
2009
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
CA
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2011
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
NV
2010
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
CA
2010
Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2010
Maximizing the growth potential for our marketed drugs, Fusilev and Zevalin. The companys near-term outlook depends on sales and marketing successes associated with our two...
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
DE
2009
Amendment to Sales Agreement, dated as of October 19, 2001, by and between Registrant and Cantor Fitzgerald & Co
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2001
Amendment to Sales Agreement, dated as of October 19, 2001, by and between Registrant and Cantor Fitzgerald & Co
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2001
Amendment to Sales Agreement, dated as of October 19, 2001, by and between Registrant and Cantor Fitzgerald & Co
Sales Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2001